TNF, LTA and TGFB1 genotype distributions among acute graft-vs-host disease subsets after HLA-matched unrelated hematopoietic stem cell transplantation: A pilot study

Tissue Antigens

Volumn 74, Issue 1, 2009, Pages 50-56

  Shah, R ^a   Selby, S T ^a   Yokley, B ^a   Slack, R S ^a   Hurley, C K ^a   Posch, P E ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytokines; Graft vs host disease; Hematopoietic stem cell transplantation; Polymorphism

Indexed keywords

LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLELE; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; MALE; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 66949159821     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01257.x     Document Type: Article

References (35)

1. Hart DP, Peggs KS. Current status of allogeneic stem cell transplantation for treatment of hematologic malignancies. Clin Pharmacol Ther 2007 : 82 : 325 9.
2. Alderuccio F, Siatskas C, Chan J et al. Haematopoietic stem cell gene therapy to treat autoimmune disease. Curr Stem Cell Res Ther 2006 : 1 : 279 87.
3. Lee SJ, Klein J, Haagenson M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007 : 110 : 4576 83.
4. Riddell SR, Appelbaum FR. Graft-versus-host disease: a surge of developments. PLoS Med 2007 : 4 : e198.
5. Mullighan CG, Petersdorf EW. Genomic polymorphism and allogeneic hematopoietic transplantation outcome. Biol Blood Marrow Transplant 2006 : 12 : 19 27. (Pubitemid 43034115)
6. Petersdorf EW, Malkki M. Genetics of risk factors for graft-versus-host disease. Semin Hematol 2006 : 43 : 11 23. (Pubitemid 43063331)
7. Hill GR, Krenger W, Ferrara JL. The role of cytokines in acute graft-versus-host disease. Cytokines Cell Mol Ther 1997 : 3 : 257 66.
8. Ferrara JL. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000 : 9 : 299 306. (Pubitemid 30436458)
9. Visentainer JE, Lieber SR, Persoli LB et al. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation. Exp Hematol 2003 : 31 : 1044 50.
10. Haukim N, Bidwell JL, Smith AJP et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 2002 : 3 (Suppl. 2 313 30.
11. Bunnapradist S, Jordan SC. The role of cytokines and cytokine gene polymorphism in T-cell activation and allograft rejection. Ann Acad Med Singapore 2000 : 29 : 412 6.
12. Tambur AR, Yaniv I, Stein J et al. Cytokine gene polymorphism in patients with graft-versus-host disease. Transplant Proc 2001 : 33 : 502 3.
13. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974 : 18 : 295 304.
14. Posch PE, Cruz I, Bradshaw D, Medhekar BA. Novel polymorphisms and the definition of promoter 'alleles' of the tumor necrosis factor and lymphotoxin alpha loci: inclusion in HLA haplotypes. Genes Immun 2003 : 4 : 547 58.
15. Takahashi H, Furukawa T, Hashimoto S et al. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 2000 : 26 : 1317 23.
16. Rocha V, Franco RF, Porcher R et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002 : 100 : 3908 18.
17. Middleton PG, Taylor PRA, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998 : 10 : 3943 8.
18. Malkki M, Gooley T, Dubois V, Horowitz M, Petersdorf EW. Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation. Tissue Antigens 2007 : 69 (Suppl. 1 50 3.
19. Ishikawa Y, Kashiwase K, Akaza T et al. Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 2002 : 29 : 569 75.
20. Bogunia-Kubik K, Polak M, Lange A. TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 2003 : 32 : 617 22.
21. Shah R, Rahaman B, Hurley CK, Posch PE. Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 2006 : 119 : 61 74. (Pubitemid 43300198)
22. Hattori H, Matsuzaki A, Suminoe A et al. Polymorphisms of transforming growth factor-β1 and transforming growth factor-β1 receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant 2002 : 30 : 665 71.
23. Leffell MS, Vogelsang GB, Lucas DP, Delaney NL, Zachary AA. Association between TGF-β expression and severe GVHD in allogeneic bone marrow transplantation. Transplant Proc 2001 : 33 : 485 6.
24. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998 : 16 : 137 61.
25. Horwitz DA, Zheng SG, Gray JD. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. J Leukoc Biol 2003 : 74 : 471 8.
26. Devetten MP, Vose JM. Graft-versus-host disease: how to translate new insights into new therapeutic strategies. Biol Blood Marrow Transplant 2004 : 10 : 815 25.
27. Ozaki K, Ohnishi Y, Iida A et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002 : 32 : 650 4.
28. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood 1995 : 85 : 2607 18.
29. Poritz LS, Page MJ, Tilberg AF, Koltun WA. Amelioration of graft versus host disease with anti-ICAM-1 therapy. J Surg Res 1998 : 80 : 280 6.
30. Malkki M, Gooley TA, Horowitz MM et al. Mapping MHC-resident transplantation determinants. Biol Blood Marrow Transplant 2007 : 13 : 986 95.
31. Malkki M, Gooley TA, Horowitz MM, Petersdorf EW. MHC class I, II and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation. Tissue Antigens 2007 : 69 (Suppl. 1 46 9.
32. Bogunia-Kubik K, Lange A. HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease. Transplantation 2005 : 79 : 815 20.
33. Battiwalla M, Hahn T, Radovic M et al. Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence. Blood 2006 : 107 : 1970 3.
34. Martin PF, Gooley T, Anasetti C, Petersdorf EW, Hansen FA. HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling. Biol Blood Marrow Transplant 1998 : 4 : 128 33.
35. Lachin JM. Sample size determinations for R×C comparative trials. Biometrics 1997 : 33 : 315 24.